The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...
An Administrative Inquiry was ordered at Volos Hospital, following the complaint by parents that a four-month-old infant ...
5d
Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...
Fluid administration above an infant's requirement can delay postnatal diuresis and subsequent recovery from RDS. All fluids including fat emulsion and medication continuous infusions should be ...
As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
After hours: February 14 at 5:59:51 PM EST Loading Chart for HALO ...
After hours: February 14 at 7:58:50 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback